Neda Safarzadeh
Investor Relations Contact chez ARCTURUS THERAPEUTICS HOLDINGS INC.
Profil
Neda Safarzadeh is currently the Head-Marketing, Investor & Public Relations at Arcturus Therapeutics Ltd.
since 2013 and the VP, Head-Marketing, Investor & Public Relations at Arcturus Therapeutics Holdings, Inc. since 2022.
Previously, she worked as the Head-Marketing, Public & Investor Relations at Marker Therapeutics, Inc. in 2022.
She also held a position in Investor Relations & Media Contact at Arcturus Therapeutics Holdings, Inc. Additionally, Ms. Safarzadeh completed her undergraduate degree at the University of California San Diego.
Postes actifs de Neda Safarzadeh
| Sociétés | Poste | Début |
|---|---|---|
| ARCTURUS THERAPEUTICS HOLDINGS INC. | Investor Relations Contact | 01/12/2022 |
Arcturus Therapeutics Ltd.
 Arcturus Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Arcturus Therapeutics Ltd. engages in the provision of RNA medicines, which focuses on liver and respiratory diseases. Its RNA medicines include mRNA; siRNA, miRNA, and ASO;, CRISPR, TALEN, and meganucleases; and Replicon RNA and DNA. The company was founded by Joseph Payne in March 2013 and is headquartered in San Diego, CA. | Investor Relations Contact | 01/04/2013 |
Anciens postes connus de Neda Safarzadeh
| Sociétés | Poste | Fin |
|---|---|---|
| MARKER THERAPEUTICS, INC. | Investor Relations Contact | 01/12/2022 |
| ARCTURUS THERAPEUTICS HOLDINGS INC. | Investor Relations Contact | 02/01/2022 |
Formation de Neda Safarzadeh
| University of California San Diego | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| MARKER THERAPEUTICS, INC. | Health Technology |
| ARCTURUS THERAPEUTICS HOLDINGS INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Arcturus Therapeutics Ltd.
Arcturus Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Arcturus Therapeutics Ltd. engages in the provision of RNA medicines, which focuses on liver and respiratory diseases. Its RNA medicines include mRNA; siRNA, miRNA, and ASO;, CRISPR, TALEN, and meganucleases; and Replicon RNA and DNA. The company was founded by Joseph Payne in March 2013 and is headquartered in San Diego, CA. | Health Technology |
